font size
Sign inprintPrint
TAXES

Life Science Companies Face A Taxing Problem

Podcast: December 4, 2009

The Burrill Report (December 4, 2009): Life Science Companies Face A Taxing Problem (.MP3,10.81 Mb)

The global financial crisis and healthcare reform efforts around the world will likely drive up the effective tax rate for the pharmaceutical and life sciences companies, according to a new report from PricewaterhouseCoopers. At the same time countries looking to attract research and development and manufacturing to bolster their economies are offering tax incentives to lure pharmaceutical companies. We spoke to Michael Swanick, partner and global pharmaceutical and life sciences tax leader for PricewaterhouseCoopers about the changing tax environment for pharmaceutical companies, potential areas of new tax obligations, and the growing complexity of managing these issues.

[Please login to post comments]

Other recent stories

Sign Up to recevie the Burrill Weekly Brief

The Journal of Life Sciences



  Burrill Select   NSDQ Biotech   BIOTECH  
     923.97 -4.82 (-0.52%)
     837.68 -5.20 (-0.62%)
     1052.01 - (+0.00)
  Index Last Change (%)
     Burrill Select 923.97 -4.82 (-0.52%)
     NSDQ Biotech 837.68 -5.20 (-0.62%)
     BIOTECH 1052.01 - (+0.00)
     Amex Pharm 271.23 - (+0.00)
     Nasdaq 2257.04 -20.64 (-0.91%)
     S&P 500 1089.41 - (+0.00)
     NYSE 6791.57 -101.72 (-1.48%)
     RUS 2K 661.61 -8.90 (-1.33%)
Quotes delayed at least 20 mins.
Get Quote